Business Context and Reporting Period
This Form 8-K filing by Community Health Systems, Inc. (CHS) was submitted on February 27, 2015, reporting events occurring on February 25, 2015. The filing details the Board of Directors' approval of compensation arrangements for Named Executive Officers (NEOs), including 2014 incentive payments, 2015 base salaries, 2015 performance targets, and long-term equity grants.
Key Financial Metrics and Compensation Data
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the company. It focuses exclusively on executive compensation figures.
2014 Incentive Compensation Payments
| Executive | Target Attained | Payment Amount |
|---|---|---|
| Wayne T. Smith (CEO) | 92% | $4,117,500 |
| W. Larry Cash (CFO) | 92% | $1,464,000 |
| David L. Miller (COO) | 90% | $1,255,100 |
| William S. Hussey (Division President) | 94% | $913,250 |
| Thomas D. Miller (Division President) | 63% | $614,250 |
| Rachel A. Seifert (EVP/GC) | 90% | $813,000 |
2015 Base Salaries
| Executive | 2015 Base Salary |
|---|---|
| Wayne T. Smith (CEO) | $1,600,000 |
| W. Larry Cash (CFO) | $850,000 |
| David L. Miller (COO) | $750,000 |
| William S. Hussey (Division President) | $675,000 |
| Thomas D. Miller (Division President) | $675,000 |
| Rachel A. Seifert (EVP/GC) | $630,000 |
2015 Equity Grants (Effective March 1, 2015)
Performance-Based Restricted Shares were granted to NEOs. No Non-Qualified Stock Options were granted.
- CEO: 150,000 shares
- CFO: 75,000 shares
- COO: 50,000 shares
- Division Presidents (each): 35,000 shares
- EVP/GC: 35,000 shares
- All other executives (group): 200,000 shares
Material Changes and Plan Structure
The filing outlines a shift in compensation structure for 2015, introducing specific performance metrics tied to the Affordable Care Act and government investigations. The 2014 incentive payments varied by role; Division Presidents had lower attainment percentages (63% to 94%) compared to C-suite executives (90% to 92%) due to different goal structures involving hospital-specific margins.
For 2015, the maximum incentive opportunity as a percentage of base salary is set at 300% for the CEO and 200% for the CFO and COO. The plans include a component for relative Total Shareholder Return (TSR) against a healthcare peer group and specific non-financial goals.
2015 Performance Goals
- Financial: Company EBITDA, Continuing Operations EPS, and Net Revenues are primary drivers.
- Non-Financial: Includes physician recruitment, capital budget adherence, clinical compliance, and revenue growth tied to Affordable Care Act implementation.
- Specific to EVP/GC: Includes successful progress on resolving government investigations and departmental cost management.
Guidance, Risks, and Contingencies
The filing references the Company's earnings release filed on February 19, 2015, which contains the projected ranges for EPS and Net Operating Revenues used as performance hurdles for the 2015 equity grants. The filing does not provide new forward-looking financial guidance beyond these referenced targets.
Risks and Contingencies:
- Equity Forfeiture: Performance-based restricted shares will be forfeited entirely if the Company fails to meet 75% of the low end of projected EPS or 90% of the low end of projected Net Operating Revenues for 2015.
- Government Investigations: The EVP/GC's compensation is explicitly tied to resolving government investigations, indicating an ongoing material contingency.
- Employment Agreements: None of the executive officers have written employment agreements.
Investor Verification Checklist
- Verify the specific EPS and Net Operating Revenue ranges cited in the February 19, 2015, Form 8-K earnings release to understand the vesting hurdles for the 2015 equity grants.
- Monitor the status of government investigations mentioned as a performance metric for the General Counsel.
- Review the 2014 annual report to compare the 2014 incentive payments against the company's overall financial performance for that year.
- Confirm the peer group composition used for the Total Shareholder Return (TSR) metric to assess the difficulty of that target.